Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to...